EGFR upregulates inflammatory and proliferative responses in human lung adenocarcinoma cell line (A549), induced by lower dose of cadmium chloride

Inhalation Toxicology

Volumn 23, Issue 6, 2011, Pages 339-348

  Kundu, Subhadip ^a,b   Sengupta, Suman ^a,b   Bhattacharyya, Arindam ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b UNIVERSITY OF KALYANI   (India)

Author keywords

A549 cell; CyclinD1; cytokine; EGFR; inflammation; non small cell lung carcinoma

Indexed keywords

BETA ACTIN; CADMIUM CHLORIDE; CYCLIN D1; CYCLINE; CYCLOOXYGENASE 2; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; KI 67 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EXPOSURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; LC 50; LOW DRUG DOSE; LUNG ADENOCARCINOMA; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CADMIUM CHLORIDE; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; LETHAL DOSE 50; LUNG NEOPLASMS; MICROSCOPY, ACOUSTIC; PROLIFERATING CELL NUCLEAR ANTIGEN; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; UP-REGULATION;

MUS;

EID: 79957827152     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2011.572931     Document Type: Article

References (36)

1. Alroy I, Yarden Y. 1997. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410:83-86. (Pubitemid 27283389)
2. Arteaga CL. 2003. ErbB-targeted therapeutic approaches in human cancer. Exp Cell Res 284:122-130. (Pubitemid 36331971)
3. Bakshi S, Zhang X, Godoy-Tundidor S, Cheng RY, Sartor MA, Medvedovic M, Ho SM. 2008. Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor. Environ Health Perspect 116:769-776. (Pubitemid 351943933)
4. Bierman A, Yerrapureddy A, Reddy NM, Hassoun PM, Reddy SP. 2008. Epidermal growth factor receptor (EGFR) regulates mechanical ventilation-induced lung injury in mice. Transl Res 152:265-272.
5. Calabrese EJ, Stanek EJ 3rd, Nascarella MA, Hoffmann GR. 2008. Hormesis predicts low-dose responses better than threshold models. Int J Toxicol 27:369-378. (Pubitemid 352767915)
6. Casacó A, Díaz Y, Ledón N, Merino N, Vadés O, Garcia G, Garcia B, González G, Pérez R. 2004. Effect of an EGF-cancer vaccine on wound healing and inflammation models. J Surg Res 122:130-134. (Pubitemid 39441243)
7. Chang CG, Yu Ricky CT, Tsai CH, Tsai JR, Chen CJ, Wu CC, Wu WJ, Hsu SL. 2008. An epidermal growth factor inhibitor, gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells. E J Pharmacol 600:37-44.
8. Chien SP, Mak TO, Huang JH. 2006. Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathway. Biochem Biophys Res Commun 339:562-568.
9. Croute F, Beau B, Arrabit C, Gaubin Y, Delmas F, Murat JC, Soleilhavoup JP. 2000. Pattern of stress protein expression in human lung cellline A549 after short- or long-term exposure to cadmium. Environ Health Perspect 108:55-60. (Pubitemid 30064095)
10. Enger DM, Flomerfelt AF, Piper L, Jenkins SW, Jenkins SP. 1987. Cadmium produces a delayed mitogenic response and modulates the EGF response in quiescent NRK cells. Cell Biol Toxicol 3: 407-416.
11. Hagemann T, Balkwill F, Lawrence T. 2007. Inflammation and cancer: a double-edged sword. Cancer Cell 12:300-301. (Pubitemid 47539316)
12. Hatcher EL, Chen Y, Kang YJ. 1995. Cadmium resistance in A549 cells correlates with elevated glutathione content but not antioxidant enzymatic activities. Free Radic Biol Med 19:805-812.
13. Horiguchi H, Harada A, Oguma E, Sato M, Homma Y, Kayama F, Fukushima M, Matsushima K. 2000. Cadmium-induced acute hepatic injury is exacerbated in human interleukin-8 transgenic mice. Toxicol Appl Pharmacol 163:231-239. (Pubitemid 30158552)
14. Järup L, Bellander T, Hogstedt C, Spång G. 1998. Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 55:755-759. (Pubitemid 28480317)
15. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA Cancer J Clin 57:43-66. (Pubitemid 46148091)
16. Jiang G, Duan W, Xu L, Song S, Zhu C, Wu L. 2009. Biphasic effect of cadmium on cell proliferation in human embryo lung fibroblast cells and its molecular mechanism. Toxicol In Vitro 23:973-978.
17. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. 2003. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31-53. (Pubitemid 36331965)
18. Kalish HL, Kwong AR, Cole EI, Gallagher MR, Sutherland LR, Musgrove AE. 2004. Deregulated Cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin cancer res 10: 7764-7774.
19. Kundu S, Sengupta S, Chatterjee S, Mitra S, Bhattacharyya A. 2009. Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approach. J Inflamm (Lond) 6:19.
20. Lau AT, Zhang J, Chiu JF. 2006. Acquired tolerance in cadmiumadapted lung epithelial cells: roles of the c-Jun N-terminal kinase signaling pathway and basal level of metallothionein. Toxicol Appl Pharmacol 215:1-8. (Pubitemid 44118397)
21. Lee H, Goetzl EJ, An S. 2000. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol, Cell Physiol 278:C612-C618. (Pubitemid 30154941)
22. Liang C. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nature protocols 2 (http://www.nature.com/natureprotocol).
23. Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS. 2007. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56:25-33. (Pubitemid 46356635)
24. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129-2139. (Pubitemid 38637993)
25. Magos L. 1991. Epidemiological and experimental aspects of metal carcinogenesis: physicochemical properties, kinetics, and the active species. Environ Health Perspect 95:157-189.
26. Mattson MP. 2008. Hormesis defined. Ageing Res Rev 7:1-7.
27. Mendelsohn J, Baselga J. 2006. Epidermal growth factor receptor targeting in cancer. Semin Oncol 33:369-385. (Pubitemid 44142736)
28. Øvrevik J, Refsnes M, Namork E, Becher R, Sandnes D, Schwarze PE, Låg M. 2006. Mechanisms of silica-induced IL-8 release from A549 cells: initial kinase-activation does not require EGFR activation or particle uptake. Toxicology 227:105-116. (Pubitemid 44402859)
29. Rexer BN, Engelman JA, Arteaga CL. 2009. Overcoming resistance to tyrosine kinase inhibitors: lessons learned from cancer cells treated with EGFR antagonists. Cell Cycle 8:18-22.
30. Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419-5427. (Pubitemid 32000908)
31. Sordella R, Bell DW, Haber DA, Settleman J. 2004. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305:1163-1167. (Pubitemid 39100331)
32. Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA. 2005. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med 353:133-144. (Pubitemid 41058345)
33. Waalkes MP, Anver M, Diwan BA. 1999. Carcinogenic effects of cadmium in the noble (NBL/Cr) rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate. Toxicol Sci 52:154-161. (Pubitemid 30017590)
34. Waalkes MP, Coogan TP, Barter RA. 1992. Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol 22:175-201.
35. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimäki A. 1998. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58:4997-5001. (Pubitemid 28521147)
36. Yamano T, DeCicco LA, Rikans LE. 2000. Attenuation of cadmiuminduced liver injury in senescent male fischer 344 rats: role of Kupffer cells and inflammatory cytokines. Toxicol Appl Pharmacol 162:68-75. (Pubitemid 30059022)